[company_age]35.0[/company_age][employees]201-500 employees[/employees][funding]Private equity[/funding][description]Bioton S.A. is a European biotechnology company specializing in the production of human insulin, both as an active pharmaceutical ingredient (API) and in finished forms for cartridges and vials. With over 20 years of experience, Bioton has established itself as a leading provider of safe and effective diabetes medications, holding the top position in the Polish market and ranking among the top eight commercial manufacturers of recombinant human insulin worldwide. Bioton's commitment to innovation is evident in its continuous investments in Polish biotechnology, pioneering the commercialization of research成果 in collaboration with Polish scientific institutes. The company actively seeks to improve diabetes treatment for patients by implementing the latest therapeutic and technological advancements. Bioton's comprehensive approach extends beyond insulin production, offering CMO/CDMO and QC services adhering to QbD principles and cGMP standards. Additionally, Bioton provides a range of innovative gastroenterological FSMP (Foods for Special Medical Purposes).[/description][ps]Human insulin (API and finished forms), CMO/CDMO services, QC services, innovative gastroenterological FSMP[/ps]